PPARα/γ expression and activity in mouse and human melanocytes and melanoma cells

Pharmaceutical Research

Volumn 25, Issue 6, 2008, Pages 1327-1333

  Eastham, Linda L ^a   Mills, Caroline N ^a   Niles, Richard M ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Growth inhibition; Melanocytes; Melanoma; PPAR expression

Indexed keywords

CIGLITAZONE; CRYSTAL VIOLET; LIGAND; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIRINIXIC ACID; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; WESTERN BLOTTING; ANIMAL; DRUG POTENTIATION; GENETICS; MELANOMA; METABOLISM; PHYSIOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MELANOCYTES; MELANOMA; MICE; PPAR ALPHA; PPAR GAMMA; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION;

EID: 43049132826     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9524-9     Document Type: Article

References (26)

1. S. Green. PPAR a mediator of peroxisome proliferator action. Mutat. Res. 333:101-109 (1995).
2. P. Eschser, and W. Wahli. Peroxisome proliferators-activated receptors: insight into multiple cellular functions. Mutat. Res. 448:121-138 (2000).
3. J. Berger, and D. E. Moller. The mechanisms of action of PPARs. Annu. Rev. Med. 53:409-435 (2002).
4. E. Mueller, P. Sarraf, P. Tontonoz, R. M. Evans, K. J. Martin, M. Zhang, C. Fletcher, S. Singer, and B. M. Spiegelman. Terminal differentiation of human breast cancer through PPAR γ. Mol. Cell 3:465-479 (1998).
5. S. Kawa, T. Nikaido, H. Unno, N. Usuda, K. Nakayama, and K. Kiyosawa. Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR γ ligand troglitzaone. Pancreas 24:1-7 (2002).
6. G. He, S. Muga, P. Thuillier, R. A. Lubet, and S. M. Fischer. The effect of PPAR ligands on UV- or chemically induced carcinogenesis in mouse skin. Mol. Carcinog. 43:198-206 (2005).
7. G. Boskovic, and R. M. Niles. Identification of Tbx-2 as an immediate early gene target of retinoic acid in B16 mouse melanoma cells. Exp. Cell Res. 295:281-289 (2004).
8. H. Okano, K. Shiraki, H. Inoue, Y. Yamanaka, T. Kawakita, Y. Saitou, Y. Yamaguchi, N. Enokimura, N. Yamamoto, K. Sugimoto, K. Murata, and T. Nakano. 15-Deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-kappaB activation via a peroxisome proliferators-activated receptor-γ-independent mechanism in hepatocellular carcinoma. Lab. Invest. 83:1529-1539 (2003).
9. C. S. Aung, H. M. Faddy, E. J. Lister, G. R. Moneith, and S. J. Roberts-Thomson. Isoform specific changes in PPAR α and β in colon and breast cancer with differentiation. Biochem. Biophys. Res. Commun. 340:656-660 (2005).
10. Y. Segawa, R. Yoshimura, T. Hase, T. Nakatani, S. Wada, Y. Kawahito, T. Kashimoto, and H. Sano. Expression of peroxisome proliferaor activated receptor (PPAR) in human prostate cancer. Prostate 51:108-116 (2002).
11. K. Inoue, Y. Kawahito, Y. Tsubouchi, R. Yamada, M. Kohno, Y. Hosokawa, D. Katoh, D. Bishop-Bailey, T. Hla, and H. Sano. Expression of peroxisome proliferators-activated receptor (PPAR)-γ in human lung cancer. Anticancer Res. 21:2471-2476 (2001).
12. T. Nijsten, E. Geluyckens, C. Colpaert, and J. Lambert. Peroxisome proliferators-activated receptors in squamous cell carcinoma and its precursors. J. Cutan. Pathol. 32:340-347 (2005).
13. K. M. Suchanek, F. J. May, J. A. Robinson, W. J. Lee, N. A. Holman, G. R. Monteith, and S. J. Roberts-Thomson. Peroxisome proliferators-activated receptor α in the human breast cancer cell lines MCF-7 and MDA-MB-231. Mol. Carcinog. 34:165-171 (2002).
14. P. Tontonoz, S. Singer, B. M. Forman, P. Sarraf, J. A. Fletcher, C. D. Fletcher, R. P. Vrun, E. Mueller, S. Altiok, H. Oppenheim, R. M. Evans, and B. M. Spiegelman. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proc. Natl. Acad. Sci. U.S.A. 94:237-241 (1997).
15. C. Zang, H. Liu, M. Waechter, J. Eucker, J. Bertz, K. Possinger, H. P. Koeffler, and E. Eistner. Dual alpha/gamma ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell line. Cell Cycle 5:2237-2247 (2006).
16. R. T. Miller, S. E. Glover, W. S. Stewart, J. C. Corton, J. A. Popp, and R. C. Cattley. Effect on the expression of c-met, c-myc and PPAR-α in liver and liver tumors from rats chronically exposed to the hepatoccarcinogenic peroxisome proliferators WY-14,643. Carcinogenesis 17:1337-1341 (1996).
17. J. W. Park, R. Zarnegar, H. Kanauchi, M. G. Wong, W. C. Hyun, D. G. Ginzinger, M. Lobo, P. Cotter, Q. Y. Duh, and O. H. Clark. Troglitzaone, the peroxisome proliferators-activated receptor-γ agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines. Thyroid 15:222-231 (2005).
18. N. Di-Poi, L. Michalik, B. Desvergne, and W. Wahli. Functions of peroxisome proliferators-activated receptors (PPAR) in skin homeostasis. Lipids 39:1093-1099 (2004).
19. L. Michalik, J. N. Feige, L. Gelman, T. Pedrazzini, H. Keller, B. Desvergne, and W. Wahli. Selective expression of a dominant-negative form of peroxisome proliferators-activator receptor in keratinocytes leads to impaired epidermal healing. Mol. Endocrinol. 19:2335-2348 (2005).
20. H. Y. Kang, E. Chung, M. Lee, T. Cho, and W. H. Kang. Expression and function of peroxisome proliferators-activated receptors in human melanocytes. Br. J. Dermatol. 150:462-468 (2004).
21. W. Plachaa, D. Gil, A. Dembinska-Kiec, and P. Laidler. The effect of PPAR γ ligands on the proliferation and apoptosis of human melanoma cells. Melanoma Res. 13:447-456 (2003).
22. C. Freudlsperger, I. Moll, U. Schumacher, and A. Thies. Anti-proliferative effect of peroxisome proliferators-activated receptor γ agonists on human malignant melanoma cells in vitro. Anticancer Drugs 17:325-332 (2006).
23. J. S. Lee, Y. M. Choi, and H. Y. Chang. PPAR-γ agonist, ciglitazone, increases pigmentation and migration of human melanocytes. Exp. Dermatol. 16:118-123 (2007).
24. M. Selmandi, G. Lemaire, A. Pillon, A. Perrin, I. Carlavan, J. J. Voegel, F. Vignon, J. C. Nicolas, and P. Balaquer. Differential responses to PPARα, PPARδ, an PPARγ reporter cell lines to selective PPAR synthetic ligands. Anal. Biochem. 344:8-15 (2005).
25. C. L. Chaffer, D. M. Thomas, E. W. Thompson, and E. D. Williams. PPAR γ-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma. BMC Cancer 6:53 (2006).
26. Y. Liu, Y. Meng, H. Liu, J. Li, J. Fu, Y. Liu, and K. Chen. Growth inhibition and differentiation induced by peroxisome proliferators activated receptor γ ligand rosiglitazone in human melanoma cell line a375. Med. Oncol. 23:393-402 (2006).